Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Nanopharm Ltd, an Aptar Pharma CompanyNanopharm Ltd, an Aptar Pharma Company
VS
AbbVieAbbVie
Nanopharm Ltd, an Aptar Pharma Company

Nanopharm Ltd, an Aptar Pharma Company

Franklin House, Cwmbran, undefined, NP44 3WY, GB

Last Update: 04/01/2026

View Profile
Between 750 and 799
https://nanopharm.co.uk
752/1000Fair

Nanopharm was founded to address industry-wide challenges in converting drugs from concept into viable, effective and consistent nasal and orally inhaled drug products. The company has established itself as a leading provider of tailored analytical and formulation su...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:68
Subsidiaries:9
12-month incidents
0
Known data breaches
0
Attack type number
0
AbbVie

AbbVie

1 Waukegan Road, North Chicago, 60064, US

Last Update: 10/09/2026

View Profile
Between 800 and 849
http://www.abbvie.com
827/1000Good

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:61,106
Subsidiaries:19
12-month incidents
1
Known data breaches
1
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
Nanopharm Ltd, an Aptar Pharma Company

Nanopharm Ltd, an Aptar Pharma Company

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
AbbVie

AbbVie

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Nanopharm Ltd, an Aptar Pharma Company in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

AbbVie has 2.91% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - Nanopharm Ltd, an Aptar Pharma Company (X = Date, Y = Severity)

Nanopharm Ltd, an Aptar Pharma Company cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - AbbVie (X = Date, Y = Severity)

AbbVie cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Nanopharm Ltd, an Aptar Pharma Company

Nanopharm Ltd, an Aptar Pharma Company

Incidents
No explicit notable incidents reported.
AbbVie

AbbVie

Incidents
🔒 Incident : Vulnerability
EGAABB1775658772
🔒 Incident : Breach
ABB0473723

FAQ

Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has the best AI Cybersecurity Score ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has experienced more cyber incidents in the past ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has experienced more cyber incidents this year ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has experienced at least one ransomware attack ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has experienced at least one data breach ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has experienced at least one targeted cyberattack ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has experienced at least one vulnerability ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one holds the most compliance certifications ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one holds the fewest compliance certifications ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has the most subsidiaries ?
Between Nanopharm Ltd, an Aptar Pharma Company company and AbbVie company, which one has the largest number of employees ?
Between Nanopharm Ltd, an Aptar Pharma Company and AbbVie, which company holds both SOC 2 Type 1 certifications ?
Between Nanopharm Ltd, an Aptar Pharma Company and AbbVie, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Nanopharm Ltd, an Aptar Pharma Company or AbbVie ?
Which company is PCI DSS compliant - Nanopharm Ltd, an Aptar Pharma Company or AbbVie ?
Between Nanopharm Ltd, an Aptar Pharma Company and AbbVie, which company complies with HIPAA regulations for healthcare data ?
Between Nanopharm Ltd, an Aptar Pharma Company and AbbVie, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-16174
SUMMARY

Netskope was notified about a potential gap in Netskope Endpoint DLP (EPDLP) running on Windows systems. Successful exploitation of the gap could potentially allow a privileged user to send a crafted message to the EPDLP process port to trigger an integer overflow, leading to memory corruption. Successful exploitation would require the EPDLP module to be enabled in the client configuration, and that Memory Integrity is disabled. A successful exploit could potentially result in a denial-of-service, arbitrary code execution, or privilege escalation on the local machine.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: )
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:P/PR:H/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-16172
SUMMARY

Netskope was notified of an out-of-bounds heap read affecting the Endpoint DLP (EPDLP) service of the Netskope Client. A local standard user could potentially send a specially crafted message that is not properly validated with a bounds check, likely crashing the kernel driver handler. Successful exploitation could potentially crash the EPDLP service, temporarily interrupting DLP enforcement. A successful exploit could potentially also reveal per-boot memory layout information to unauthorized users.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: )
CVSS4
Base Score: 6.0
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-87958
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 is vulnerable to a denial of service where a specific functionality on a Db2 server can be disabled by a privileged user under certain conditions.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-86093
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an attacker with the ability to control or impersonate a DRDA server endpoint to execute arbitrary commands on Db2 clients due to a stack-based buffer overflow that improperly copies user-controlled data into a fixed-size stack buffer without bounds checking.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.6
CVE-2026-86087
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an authenticated user to send a specially crafted request to write arbitrary files on the system.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8